# A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)

> **NCT02477306** · PHASE1 · COMPLETED · sponsor: **Genuine Research Center, Egypt** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Idiazole 20mg DR tabs
- **DRUG:** PARIET 20 mg DR tabs

## Key facts

- **NCT ID:** NCT02477306
- **Lead sponsor:** Genuine Research Center, Egypt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02477306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02477306, "A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02477306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*